Rhythm Pharmaceuticals, Inc. (BMV:RYTM)

Rhythm Pharmaceuticals Statistics

Total Valuation

BMV:RYTM has a market cap or net worth of MXN 108.95 billion. The enterprise value is 106.44 billion.

Market Cap	108.95B
Enterprise Value	106.44B

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	66.74M
Shares Outstanding	n/a
Shares Change (YoY)	+6.54%
Shares Change (QoQ)	+0.93%
Owned by Insiders (%)	0.79%
Owned by Institutions (%)	89.52%
Float	55.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.89
PB Ratio	22.41
P/TBV Ratio	45.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.28
EV / Sales	32.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-50.69

Financial Position

The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.42.

Current Ratio	4.41
Quick Ratio	3.92
Debt / Equity	0.42
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-9.33

Financial Efficiency

Return on equity (ROE) is -90.45% and return on invested capital (ROIC) is -36.34%.

Return on Equity (ROE)	-90.45%
Return on Assets (ROA)	-27.51%
Return on Invested Capital (ROIC)	-36.34%
Return on Capital Employed (ROCE)	-51.31%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	12.07M
Profits Per Employee	-12.85M
Employee Count	283
Asset Turnover	0.43
Inventory Turnover	0.88

Taxes

In the past 12 months, BMV:RYTM has paid 8.95 million in taxes.

Income Tax	8.95M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +94.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+94.86%
50-Day Moving Average	577.77
200-Day Moving Average	n/a
Relative Strength Index (RSI)	78.94
Average Volume (20 Days)	3,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.76

Income Statement

In the last 12 months, BMV:RYTM had revenue of MXN 3.42 billion and -3.64 billion in losses. Loss per share was -55.94.

Revenue	3.42B
Gross Profit	3.07B
Operating Income	-3.46B
Pretax Income	-3.53B
Net Income	-3.64B
EBITDA	-3.43B
EBIT	-3.46B
Loss Per Share	-55.94

Balance Sheet

The company has 7.00 billion in cash and 2.02 billion in debt, with a net cash position of 4.98 billion.

Cash & Cash Equivalents	7.00B
Total Debt	2.02B
Net Cash	4.98B
Net Cash Per Share	n/a
Equity (Book Value)	4.86B
Book Value Per Share	37.25
Working Capital	6.50B

Cash Flow

In the last 12 months, operating cash flow was -2.08 billion and capital expenditures -17.16 million, giving a free cash flow of -2.10 billion.

Operating Cash Flow	-2.08B
Capital Expenditures	-17.16M
Free Cash Flow	-2.10B
FCF Per Share	n/a

Margins

Gross margin is 89.73%, with operating and profit margins of -101.19% and -103.57%.

Gross Margin	89.73%
Operating Margin	-101.19%
Pretax Margin	-103.31%
Profit Margin	-103.57%
EBITDA Margin	-100.49%
EBIT Margin	-101.19%
FCF Margin	n/a

Dividends & Yields

BMV:RYTM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.54%
Shareholder Yield	-6.54%
Earnings Yield	-3.34%
FCF Yield	-1.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:RYTM has an Altman Z-Score of 10.8 and a Piotroski F-Score of 5.

Altman Z-Score	10.8
Piotroski F-Score	5